1: Ryu JH, Park JS, Jo MH, Kim JI, Shim WS, Kim BH, Yim SV, Hong J, Lee KT.
Development and validation of an LC-MS/MS method for the determination of
pelubiprofen and its active metabolite, trans-alcohol, in human plasma and its
application to pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life
Sci. 2015 Mar 1;983-984:62-7. doi: 10.1016/j.jchromb.2014.12.037. Epub 2015 Jan
15. PubMed PMID: 25618252.
2: Choi IA, Baek HJ, Cho CS, Lee YA, Chung WT, Park YE, Lee YJ, Park YB, Lee J,
Lee SS, Yoo WH, Song JS, Kang SW, Kim HA, Song YW. Comparison of the efficacy and
safety profiles of a pelubiprofen versus celecoxib in patients with rheumatoid
arthritis: a 6-week, multicenter, randomized, double-blind, phase III,
non-inferiority clinical trial. BMC Musculoskelet Disord. 2014 Nov 18;15:375.
doi: 10.1186/1471-2474-15-375. PubMed PMID: 25403311; PubMed Central PMCID:
PMC4247700.
3: Song SH, Chae BR, Sohn SI, Yeom DW, Son HY, Kim JH, Kim SR, Lee SG, Choi YW.
Formulation of controlled-release pelubiprofen tablet using Kollidon(®) SR. Int J
Pharm. 2016 Sep 25;511(2):864-75. doi: 10.1016/j.ijpharm.2016.07.074. Epub 2016
Aug 1. PubMed PMID: 27492018.
4: Shin JS, Baek SR, Sohn SI, Cho YW, Lee KT. Anti-inflammatory effect of
pelubiprofen, 2-[4-(oxocyclohexylidenemethyl)-phenyl]propionic acid, mediated by
dual suppression of COX activity and LPS-induced inflammatory gene expression via
NF-κB inactivation. J Cell Biochem. 2011 Dec;112(12):3594-603. doi:
10.1002/jcb.23290. PubMed PMID: 21809372.
5: Itoh K, Yamamoto K, Adachi M, Kosaka T, Tanaka Y. Leukotriene B4
12-hydroxydehydrogenase/15-ketoprostaglandin Delta 13-reductase (LTB4 12-HD/PGR)
responsible for the reduction of a double-bond of the alpha,beta-unsaturated
ketone of an aryl propionic acid non-steroidal anti-inflammatory agent CS-670.
Xenobiotica. 2008 Mar;38(3):249-63. doi: 10.1080/00498250701767667 . PubMed PMID:
18274955.
6: Asami M, Takasaki W, Iwabuchi H, Haruyama H, Wachi K, Terada A, Tanaka Y.
Stereospecific taurine conjugation of the trans-OH metabolite (active metabolite)
of CS-670, a new 2-arylpropionic acid nonsteroidal anti-inflammatory drug, in
dogs. Biol Pharm Bull. 1995 Nov;18(11):1584-9. PubMed PMID: 8593485.
7: Terada A, Naruto S, Wachi K, Tanaka S, Iizuka Y, Misaka E. Synthesis and
antiinflammatory activity of [(cycloalkylmethyl)phenyl]acetic acids and related
compounds. J Med Chem. 1984 Feb;27(2):212-6. PubMed PMID: 6607354.
8: Asami M, Shigeta A, Tanaka Y. Disposition of CS-670, a novel nonsteroidal
anit-inflammatory drug, and its metabolites in healthy human volunteers.
Chirality. 1996;8(2):207-13. PubMed PMID: 8857182.
9: Asami M, Yamamura M, Takasaki W, Tanaka Y. Quantitative determination of diol
metabolites of CS-670, a new antiinflammatory agent, by capillary column gas
chromatography-mass spectrometry. J Chromatogr B Biomed Appl. 1995 Mar
10;665(1):107-16. PubMed PMID: 7795780.
10: Takasaki W, Asami M, Muramatsu S, Hayashi R, Tanaka Y, Kawabata K, Hoshiyama
K. Stereoselective determination of the active metabolites of a new
anti-inflammatory agent (CS-670) in human and rat plasma using antibody-mediated
extraction and high-performance liquid chromatography. J Chromatogr. 1993 Mar
5;613(1):67-77. PubMed PMID: 8458904.
11: Kobayashi K, Abe C, Iizuka Y, Shiokawa Y. Immunomodulation by RS-2131, a new
non-steroidal antiinflammatory drug. Immunopharmacology. 1986 Dec;12(3):213-20.
PubMed PMID: 3546192.